Although MET in combination with CP did not reduce tumor growth in both xenograft models, the triple therapy consisting of KD, CP, and MET significantly reduced tumor growth (Figure 4B,E) and enhanced survival (Figure 4C,F) in both the SKNBE(2) and KELLY tumor-bearing mice. This evidence concerns the gene MET and neoplasm.